UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 231

Sortiert nach

Ursodeoxycholic acid inhibits hepatic cystogenesis in experimental models of polycystic liver disease

Journal of hepatology, 2015-10, Vol.63 (4), p.952-961

2015

Volltextzugriff (PDF)

Bile Acids in Physiology, Pathology and Pharmacology

Current drug metabolism, 2016-01, Vol.17 (1), p.4

2016

Volltextzugriff (PDF)

SIRT1 controls liver regeneration by regulating bile acid metabolism through farnesoid X receptor and mammalian target of rapamycin signaling

Hepatology (Baltimore, Md.), 2014-05, Vol.59 (5), p.1972-1983

2014

Volltextzugriff (PDF)

Differential activation of the human farnesoid X receptor depends on the pattern of expressed isoforms and the bile acid pool composition

Biochemical pharmacology, 2013-10, Vol.86 (7), p.926-939

2013

Volltextzugriff (PDF)

Molecular Bases of Chemoresistance in Cholangiocarcinoma

Current drug targets, 2017-01, Vol.18 (8), p.889

2017

Volltextzugriff (PDF)

Role of drug transport and metabolism in the chemoresistance of acute myeloid leukemia

Blood reviews, 2016-01, Vol.30 (1), p.55-64

2016

Volltextzugriff (PDF)

Leishmania heme uptake involves LmFLVCRb, a novel porphyrin transporter essential for the parasite

Cellular and molecular life sciences : CMLS, 2020-05, Vol.77 (9), p.1827-1845

2020

Volltextzugriff (PDF)

Mitochondrial genome depletion in human liver cells abolishes bile acid-induced apoptosis: Role of the Akt/mTOR survival pathway and Bcl-2 family proteins

Free radical biology & medicine, 2013-08, Vol.61, p.218-228

2013

Volltextzugriff (PDF)

The outcome of boosting mitochondrial activity in alcohol-associated liver disease is organ-dependent

Hepatology (Baltimore, Md.), 2023-09, Vol.78 (3), p.878-895

2023

Volltextzugriff (PDF)

Interaction of glucocorticoids with FXR/FGF19/FGF21-mediated ileum-liver crosstalk

Biochimica et biophysica acta. Molecular basis of disease, 2018-09, Vol.1864 (9), p.2927-2937

2018

Volltextzugriff (PDF)

Inhibition of Na+-Taurocholate Co-transporting Polypeptide-mediated Bile Acid Transport by Cholestatic Sulfated Progesterone Metabolites

The Journal of biological chemistry, 2010-05, Vol.285 (22), p.16504-16512

2010

Volltextzugriff (PDF)

Serum extracellular vesicles contain protein biomarkers for primary sclerosing cholangitis and cholangiocarcinoma

Hepatology (Baltimore, Md.), 2017-10, Vol.66 (4), p.1125-1143

2017

Volltextzugriff (PDF)

Unmet needs in basic and translational research in Cholangiocarcinoma

Liver cancer international, 2022-02, Vol.3 (1), p.5-16

2022

Volltextzugriff (PDF)

Lack of Abcc3 expression impairs bile-acid induced liver growth and delays hepatic regeneration after partial hepatectomy in mice

Journal of hepatology, 2012-02, Vol.56 (2), p.367-373

2012

Volltextzugriff (PDF)

Molecular bases of the excretion of fetal bile acids and pigments through the fetal liver-placenta-maternal liver pathway

Annals of hepatology, 2005-04, Vol.4 (2), p.70-76

2005

Volltextzugriff (PDF)

Molecular Bases of Drug Resistance in Hepatocellular Carcinoma

Cancers, 2020-06, Vol.12 (6), p.1663

2020

Volltextzugriff (PDF)

ACOX2 deficiency: An inborn error of bile acid synthesis identified in an adolescent with persistent hypertransaminasemia

Journal of hepatology, 2017-03, Vol.66 (3), p.581-588

2017

Volltextzugriff (PDF)

Expression of SLC22A1 variants may affect the response of hepatocellular carcinoma and cholangiocarcinoma to sorafenib

Hepatology (Baltimore, Md.), 2013-09, Vol.58 (3), p.1065-1073

2013

Volltextzugriff (PDF)

The search for novel diagnostic and prognostic biomarkers in cholangiocarcinoma

Biochimica et biophysica acta. Molecular basis of disease, 2018-04, Vol.1864 (4), p.1468-1477

2018

Volltextzugriff (PDF)

MicroRNA‐506 promotes primary biliary cholangitis–like features in cholangiocytes and immune activation

Hepatology (Baltimore, Md.), 2018-04, Vol.67 (4), p.1420-1440

2018

Volltextzugriff (PDF)

Modulation of intestinal barrier function by glucocorticoids: Lessons from preclinical models

Pharmacological research, 2022-03, Vol.177, p.106056-106056, Article 106056

2022

Volltextzugriff (PDF)

TREM-2 plays a protective role in cholestasis by acting as a negative regulator of inflammation

Journal of hepatology, 2022-10, Vol.77 (4), p.991-1004

2022

Volltextzugriff (PDF)

Maternal cholestasis during pregnancy programs metabolic disease in offspring

The Journal of clinical investigation, 2013-07, Vol.123 (7), p.3172-3181

2013

Volltextzugriff (PDF)

Impact of tumor suppressor genes inactivation on the multidrug resistance phenotype of hepatocellular carcinoma cells

Biomedicine & pharmacotherapy, 2023-09, Vol.165, p.115209-115209, Article 115209

2023

Volltextzugriff (PDF)

1 – 25 von 231

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(219)
Mit Volltextzugriff
(208)

Publikationsform

Sprache

Englisch
(231)
Japanisch
(50)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Ursodeoxycholic acid inhibits hepatic cystogenesis in experimental models of polycystic liver disease

Bile Acids in Physiology, Pathology and Pharmacology

SIRT1 controls liver regeneration by regulating bile acid metabolism through farnesoid X receptor and mammalian target of rapamycin signaling

Differential activation of the human farnesoid X receptor depends on the pattern of expressed isoforms and the bile acid pool composition

Molecular Bases of Chemoresistance in Cholangiocarcinoma

Role of drug transport and metabolism in the chemoresistance of acute myeloid leukemia

Leishmania heme uptake involves LmFLVCRb, a novel porphyrin transporter essential for the parasite

Mitochondrial genome depletion in human liver cells abolishes bile acid-induced apoptosis: Role of the Akt/mTOR survival pathway and Bcl-2 family proteins

The outcome of boosting mitochondrial activity in alcohol-associated liver disease is organ-dependent

Interaction of glucocorticoids with FXR/FGF19/FGF21-mediated ileum-liver crosstalk

Inhibition of Na+-Taurocholate Co-transporting Polypeptide-mediated Bile Acid Transport by Cholestatic Sulfated Progesterone Metabolites

Serum extracellular vesicles contain protein biomarkers for primary sclerosing cholangitis and cholangiocarcinoma

Unmet needs in basic and translational research in Cholangiocarcinoma

Boosting mitochondria activity by silencing MCJ overcomes cholestasis-induced liver injury

Lack of Abcc3 expression impairs bile-acid induced liver growth and delays hepatic regeneration after partial hepatectomy in mice

Molecular bases of the excretion of fetal bile acids and pigments through the fetal liver-placenta-maternal liver pathway

Molecular Bases of Drug Resistance in Hepatocellular Carcinoma

ACOX2 deficiency: An inborn error of bile acid synthesis identified in an adolescent with persistent hypertransaminasemia

Expression of SLC22A1 variants may affect the response of hepatocellular carcinoma and cholangiocarcinoma to sorafenib

The search for novel diagnostic and prognostic biomarkers in cholangiocarcinoma

MicroRNA‐506 promotes primary biliary cholangitis–like features in cholangiocytes and immune activation

Modulation of intestinal barrier function by glucocorticoids: Lessons from preclinical models

TREM-2 plays a protective role in cholestasis by acting as a negative regulator of inflammation

Maternal cholestasis during pregnancy programs metabolic disease in offspring

Impact of tumor suppressor genes inactivation on the multidrug resistance phenotype of hepatocellular carcinoma cells

Suchergebnisse filtern